http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10123573-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b9d05fb4b598852a9b310752f43a5fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0978221c5ec1ad380ebc424b85469c82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3203dd25c3d8e088302bdf1a4490911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29042e398c3edaaac18f0274fc190d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f85180101001463316342cf1b51693b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02c5acdf8352ac2f8f442837699dfa0 |
| publicationDate | 2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-10123573-A1 |
| titleOfInvention | N-oxidanthranylamide derivatives and their use as medicines |
| abstract | Substituted N-oxidanthranylamide derivatives, their preparation and use as medicaments for the treatment of diseases which are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or for psoriasis, Kaposis sarcoma, restenosis, endometriosis, Crohn's disease, Hodgkins disease, leukemia, arthritis, such as rheumatoid arthritis, hemangioma, angiofribroma, eye diseases, such as diabetic retinopathy, neovascular glaucoma, kidney diseases, such as kidney diseases, such as diabetic nephropathy, malignant nephrosclerosis, thrombic microangiopatic syndromes, transplant rejections and glomerulopathy, fibrotic diseases such as cirrhosis of the liver, mesangial cell proliferative diseases, atherosclerosis, nerve tissue injuries and inhibition of the reocclusion of vessels after the use of devices or balloon catheterization for post-vascular treatment, post-vascular rejection devices, post-vascular devices, and post-catheterization Vessels such as B. stents, as immunosuppressants, as support for scar-free wound healing, age spots and contact dermatitis. |
| priorityDate | 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 395.